Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 July 1997 | Volume 127 Issue 1 | Pages 21-26
Background: Most known mutations in the gene associated with Wilson disease are rare. Only the His 1069Gln mutation is found often in patients of Northern or Eastern European origin.
Objective: To examine the frequency of the His 1069Gln mutation in Austrian patients with Wilson disease and their families by using a new, rapid polymerase chain reaction (PCR) test.
Design: Cross-sectional study.
Setting: University medical center.
Patients: 83 patients from 72 families and 98 relatives of 11 homozygous index patients.
Measurements: Results of a semi-nested PCR-based assay to detect the His 1069Gln mutation in Wilson disease, clinical symptoms, and liver histologic findings.
Results: 20 patients, including 5 siblings, were homozygous for the His1069Gln mutation. Thirty-three patients, including 4 siblings, were compound heterozygotes. The mutation was not detected in 30 patients, including 2 siblings. Homozygotes were older at onset of symptoms (mean age, 24 ± 6 years) than compound heterozygotes (17 ± 6 years [95% CI, 3.3 to 10.7 years]; P = 0.0135) and patients with other mutations (18 ± 8 years [CI, 1.8 to 10.2 years]; P = 0.117). Homozygotes were more often female (73.3%) than were compound heterozygotes (48% [CI, 0.94% to 2.46%]) and patients with other mutations (50% [CI, 0.91% to 2.37%]) (P = 0.05). Four of 98 asymptomatic relatives of 11 homozygous index patients were also homozygotes. Heterozygosity was confirmed in 46 relatives (19 parents, 11 children, and 16 distant relatives).
Conclusion: The His 1069Gln mutation was detected in 61% of Austrian patients with Wilson disease. Polymerase chain reaction may be useful for diagnosis and screening of family members of homozygous index patients, even if first-degree relatives are not available for examination.
Author and Article Information
From University of Vienna, Vienna, Austria: University of Sheffield, Sheffield, United Kingdom; University of Cologne, Cologne, Germany; General Hospital of Salzburg, Salzburg, Austria; and University of Innsbruck, Innsbruck, Austria.
ARTICLE
Detection of the His1069Gln Mutation in Wilson Disease by Rapid Polymerase Chain Reaction
![]()
Acknowledgments: The authors thank the members of the families who participated in the study; Drs. Gerhard Granditsch, Bruno Schneewei ß, Kurt Erhart, Jozef Holoman, Felix Stockenhuber, Rudolf Stauber, Aniko Somogyi, and Christa Binder for allowing us to examine their patients and providing clinical information; Dr. Edmund Cauza for help in collecting blood samples; and Mr. Cyrus Yeganehfar for technical help.
Grant Support: In part by the Medizinisch-wissenschaftlicher Fonds des Burgermeisters der Bundeshauptstadt Wien.
Requests for Reprints: Theresia Maier-Dobersberger, MD, Department of Internal Medicine IV, Gastroenterology and Hepatology, University of Vienna, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.
Current Author Addresses: Drs. Maier-Dobersberger, Ferenci, and Gangl and Ms. Polli: Department of Internal Medicine IV, Gastroenterology and Hepatology, University of Vienna, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.
This article has been cited by other articles:
![]() |
P de Bie, P Muller, C Wijmenga, and L W J Klomp Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes J. Med. Genet., November 1, 2007; 44(11): 673 - 688. [Abstract] [Full Text] [PDF] |
||||
![]() |
U Merle, M Schaefer, P Ferenci, and W Stremmel Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study Gut, January 1, 2007; 56(1): 115 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.K. Prashanth, A.B. Taly, S. Sinha, S. Ravishankar, G.R. Arunodaya, M.K. Vasudev, and H.S. Swamy Prognostic factors in patients presenting with severe neurological forms of Wilson's disease QJM, August 1, 2005; 98(8): 557 - 563. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schiefermeier, H. Kollegger, C. Madl, C. Polli, W. Oder, H.-J. Kuhn, F. Berr, and P. Ferenci The impact of apolipoprotein E genotypes on age at onset of symptoms and phenotypic expression in Wilson's disease Brain, March 1, 2000; 123(3): 585 - 590. [Abstract] [Full Text] [PDF] |
||||